Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rivas

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|June 27, 2024
Potential of CBD Acting on Cannabinoid Receptors CB<sub>1</sub> and CB<sub>2</sub> in Ischemic StrokeIu Raïch, Jaume Lillo, Rafael Rivas-Santisteban, et al.
Experimental Neurology|January 12, 2023
The cannabinoid CB<sub>1</sub> receptor interacts with the angiotensin AT<sub>2</sub> receptor. Overexpression of AT<sub>2</sub>-CB<sub>1</sub> receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned ratsRafael Rivas-Santisteban, Jaume Lillo, Iu Raïch, et al.
Pharmacological Research|May 17, 2020
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoidsRafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, et al.
Neurobiology of Disease|November 2, 2023
Boolean analysis shows a high proportion of dopamine D<sub>2</sub> receptors interacting with adenosine A<sub>2A</sub> receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's diseaseRafael Rivas-Santisteban, Alberto José Rico, Ana Muñoz, et al.
Biochemical Pharmacology|September 9, 2018
Cannabidiol skews biased agonism at cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors with smaller effect in CB<sub>1</sub>-CB<sub>2</sub> heteroreceptor complexesGemma Navarro, Irene Reyes-Resina, Rafael Rivas-Santisteban, et al.
Pharmacological Research|November 10, 2021
Similarities and differences upon binding of naturally occurring Δ<sup>9</sup>-tetrahydrocannabinol-derivatives to cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptorsIu Raïch, Rafael Rivas-Santisteban, Alejandro Lillo, et al.
Pharmacological Research|May 30, 2020
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB<sub>1</sub>, CB<sub>2</sub> and CB<sub>1</sub>/CB<sub>2</sub> heteromer receptorsGemma Navarro, Katia Varani, Alejandro Lillo, et al.
Redox Biology|August 1, 2021
An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondriaRita Valenzuela, Ana I Rodriguez-Perez, Maria A Costa-Besada, et al.
JCI Insight|August 18, 2017
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonistMegha Garg, Adriana A de Jesus, Dawn Chapelle, et al.
Glia|March 14, 2024
Adenosine receptors are the on-and-off switch of astrocytic cannabinoid type 1 (CB1) receptor effect upon synaptic plasticity in the medial prefrontal cortexJoana Gonçalves-Ribeiro, Oksana K Savchak, Sara Costa-Pinto, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|June 27, 2024
Potential of CBD Acting on Cannabinoid Receptors CB<sub>1</sub> and CB<sub>2</sub> in Ischemic StrokeIu Raïch, Jaume Lillo, Rafael Rivas-Santisteban, et al.
Experimental Neurology|January 12, 2023
The cannabinoid CB<sub>1</sub> receptor interacts with the angiotensin AT<sub>2</sub> receptor. Overexpression of AT<sub>2</sub>-CB<sub>1</sub> receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned ratsRafael Rivas-Santisteban, Jaume Lillo, Iu Raïch, et al.
Pharmacological Research|May 17, 2020
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoidsRafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, et al.
Neurobiology of Disease|November 2, 2023
Boolean analysis shows a high proportion of dopamine D<sub>2</sub> receptors interacting with adenosine A<sub>2A</sub> receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's diseaseRafael Rivas-Santisteban, Alberto José Rico, Ana Muñoz, et al.
Biochemical Pharmacology|September 9, 2018
Cannabidiol skews biased agonism at cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors with smaller effect in CB<sub>1</sub>-CB<sub>2</sub> heteroreceptor complexesGemma Navarro, Irene Reyes-Resina, Rafael Rivas-Santisteban, et al.
Pharmacological Research|November 10, 2021
Similarities and differences upon binding of naturally occurring Δ<sup>9</sup>-tetrahydrocannabinol-derivatives to cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptorsIu Raïch, Rafael Rivas-Santisteban, Alejandro Lillo, et al.
Pharmacological Research|May 30, 2020
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB<sub>1</sub>, CB<sub>2</sub> and CB<sub>1</sub>/CB<sub>2</sub> heteromer receptorsGemma Navarro, Katia Varani, Alejandro Lillo, et al.
Redox Biology|August 1, 2021
An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondriaRita Valenzuela, Ana I Rodriguez-Perez, Maria A Costa-Besada, et al.
JCI Insight|August 18, 2017
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonistMegha Garg, Adriana A de Jesus, Dawn Chapelle, et al.
Glia|March 14, 2024
Adenosine receptors are the on-and-off switch of astrocytic cannabinoid type 1 (CB1) receptor effect upon synaptic plasticity in the medial prefrontal cortexJoana Gonçalves-Ribeiro, Oksana K Savchak, Sara Costa-Pinto, et al.
Pageof 6